(Q73864069)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10842262%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10842262%20AND%20SRC:MED&resulttype=core&format=json

amyotrophic lateral sclerosis

7 November 2019

main subject

1 reference

C Armon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10842262%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M C Graves

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10842262%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D Moses

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10842262%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D K Forté

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10842262%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

L Sepulveda

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10842262%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S M Darby

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10842262%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

R A Smith

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10842262%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10842262%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10842262%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10842262%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10842262%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

874-882

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10842262%20AND%20SRC:MED&resulttype=core&format=json

A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28200006%2923%3A6%3C874%3A%3AAID-MUS5%3E3.0.CO%3B2-U

Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28200006%2923%3A6%3C874%3A%3AAID-MUS5%3E3.0.CO%3B2-U

Motor unit number estimates and quantitative muscle strength measurements of distal muscles in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28200006%2923%3A6%3C874%3A%3AAID-MUS5%3E3.0.CO%3B2-U

Motor unit number estimate-based rates of progression of ALS predict patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28200006%2923%3A6%3C874%3A%3AAID-MUS5%3E3.0.CO%3B2-U

Linear estimates of rates of disease progression as predictors of survival in patients with ALS entering clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28200006%2923%3A6%3C874%3A%3AAID-MUS5%3E3.0.CO%3B2-U

Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology committee on Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28200006%2923%3A6%3C874%3A%3AAID-MUS5%3E3.0.CO%3B2-U

A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28200006%2923%3A6%3C874%3A%3AAID-MUS5%3E3.0.CO%3B2-U

Muscular weakness assessment: use of normal isometric strength data. The National Isometric Muscle Strength (NIMS) Database Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28200006%2923%3A6%3C874%3A%3AAID-MUS5%3E3.0.CO%3B2-U

Recombinant growth hormone treatment of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28200006%2923%3A6%3C874%3A%3AAID-MUS5%3E3.0.CO%3B2-U

Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4598%28200006%2923%3A6%3C874%3A%3AAID-MUS5%3E3.0.CO%3B2-U

10.1002/(SICI)1097-4598(200006)23:6<874::AID-MUS5>3.0.CO;2-U

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10842262%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference